Literature DB >> 2902864

Follow-up of subjects with isolated and persistent anti-core (anti-p24 or anti-p17) antibodies to HIV.

J J Lefrère1, A M Couroucé, G Lucotte, C Boitard, C Kaplan, J C Nicolas, F Bricout, P Lambin, C Doinel, J Y Muller.   

Abstract

Systematic screening of blood donations by enzyme-linked immunosorbent assay (ELISA) for HIV antibodies carries a false-positive rate: the sera involved react in Western blot to core antigens (p24 or p17) but reactivity to envelope is absent. We studied 22 subjects with persistent and isolated anti-core reactivities; 75 HIV seropositive patients were controls. The epidemiological data and the follow-up and biological tests performed in these two populations argue that donors with persistent and isolated anti-core antibodies are not seroconverting for HIV. We conclude: (1) that verification of all anti-HIV ELISA-positive sera by Western blot is essential and that the presence of at least once anti-envelope (gp120 or gp41) antibody is indispensable for the diagnosis of HIV infection; (2) that the solitary anti-p24 or anti-p17 bands observed on Western blot are false-positive. There is no evidence that donors with such reactivities are HIV-infected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902864     DOI: 10.1097/00002030-198808000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

2.  Reactivity patterns and infection status of serum samples with indeterminate Western immunoblot tests for antibody to human immunodeficiency virus type 1.

Authors:  E Ramirez; P Uribe; D Escanilla; G Sanchez; R T Espejo
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis.

Authors:  B Janvier; A Baillou; P Archinard; M Mounier; B Mandrand; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

4.  Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure.

Authors:  R T Davey; L R Deyton; J A Metcalf; M Easter; J A Kovacs; M Vasudevachari; M Psallidopoulos; L M Thompson; J Falloon; M A Polis
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.